Retrospective study of the safety of caspofungin in immunocompromised pediatric patients
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (8) , 747-749
- https://doi.org/10.1097/01.inf.0000078164.80233.14
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal CandidiasesAntimicrobial Agents and Chemotherapy, 2002
- Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patientsBritish Journal of Haematology, 2002
- Efficacy of the Echinocandin Caspofungin against Disseminated Aspergillosis and Candidiasis in Cyclophosphamide-Induced Immunosuppressed MiceAntimicrobial Agents and Chemotherapy, 2000
- Zygomycosis in the 1990s in a Tertiary-Care Cancer CenterClinical Infectious Diseases, 2000
- Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase InhibitorsAntimicrobial Agents and Chemotherapy, 2000
- Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosisAntimicrobial Agents and Chemotherapy, 1997
- Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for ManagementBlood, 1997
- Dematiaceous Fungi Are an Increasing Cause of Human DiseaseClinical Infectious Diseases, 1996
- Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcomeThe American Journal of Medicine, 1994